Study of Immune Responses to Influenza Vaccination
Recruiting now · Phase 4
Conditions studied: Influenza Vaccination
In brief
Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.
Key facts
- Study ID
- NCT03346772
- Run by
- University of Pennsylvania
- People needed
- 75
- Starts
- 2017-10-20
- Expected to finish
- 2026-07-01
- Last updated by the study team
- 2025-08-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Community-dwelling adults able to provide consent who need influenza vaccination for standard of care
You may not qualify if…
- febrile illness at time of vaccination
- active malignancy
- use of immunosuppressing medications
- blood donation in the past 60 days
- influenza vaccinated during the preceding 6 months
- allergic reactions to influenza vaccination
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.